author-photo

Jonathan O’B. Hourihane

9

Papers

24

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Improvements in Self-Reported Disease-Specific Quality of Life Among Peanut-Allergic Subjects Receiving AR101 for 28 or 56 Weeks Beyond the First Year of Treatment

2020 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (1)
Open-Label Follow-Up of the PEPITES Study (PEOPLE) to Evaluate the Long-Term Efficacy and Safety of Epicutaneous Peanut Immunotherapy in Peanut-Allergic Children

2020 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (0)
P215 ‘Have you put the fear of god into anyone today?’ – an audit measuring short term compliance with allergy clinic advice to introduce ‘safe’ foods

2019 Archives of Disease in Childhood
- Molly Cremin
- Jonathan O’B. Hourihane
Show All
- Source
- Cite
- Save
Citations (0)
P8 Follow up of sublingual immunotherapy in a paediatric population at cork university hospital

2019 Archives of Disease in Childhood
Show All
- Source
- Cite
- Save
Citations (0)
Reviews and feature articleConsensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

2015 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (2)
Recent advances in peanut allergy.

2002 Current Opinion in Allergy and Clinical Immunology
- Jonathan O’B. Hourihane
Show All
- Source
- Cite
- Save
Citations (21)